<DOC>
	<DOCNO>NCT02583425</DOCNO>
	<brief_summary>Efficacy Safety Pilot Study DFN-11 Injection Medication Overuse Headache</brief_summary>
	<brief_title>Pilot Study DFN-11 Injection Medication Overuse Headache</brief_title>
	<detailed_description />
	<mesh_term>Headache</mesh_term>
	<mesh_term>Headache Disorders , Secondary</mesh_term>
	<criteria>1 . Diagnosis medication overuse headache within past year follow category 2 . Diagnosis migraine , without aura least 12 month 3 . Experience average &gt; 10 headache day per month past 12 month 4 . Females must : i. practice effective method birth control ( e.g. , prescription oral contraceptive , contraceptive injection , contraceptive patch , intrauterine device , doublebarrier method [ e.g. , condom , diaphragm , cervical cap spermicidal foam , cream , gel ] , male partner sterilization ) entry willing continue throughout study , ii . surgically sterile , ( hysterectomy bilateral oophorectomy , tubal ligation , otherwise incapable pregnancy ) , iii . postmenopausal ( spontaneous amenorrhea least 1 year ) 5 . Females childbearing potential must negative urine pregnancy test visit . 6 . Able willing read comprehend write instruction complete electronic diary . 7 . Must internet access complete daily headache diary . 1 . Current use medication headache/migraine prophylaxis stable 30 day prior screen . Stable defined recent dose change within 30 day screen . 2 . Hemiplegic basilar migraine 3 . History , symptom sign ischemic cardiac , cerebrovascular peripheral vascular syndrome 4 . Uncontrolled hypertension ( screen systolic/diastolic blood pressure &gt; 140/90 mmHg 2 3 reading ) 5 . Clinically significant hepatic impairment 6 . History epilepsy condition associate , opinion Investigator , increase likelihood present day seizure 7 . History ( within 2 year ) drug alcohol abuse define DSMIVTR criterion 8 . Systemic disease , opinion Investigator , would contraindicate participation 9 . History neurological psychiatric condition , opinion Investigator would contraindicate participation 10 . Pregnant lactate woman 11 . Have take investigational medication within 30 day screen , schedule receive investigational drug 12 . Subjects positive urine drug screen recreational drug marijuana ( whether legal ) prescription drug explain state concomitant medication 13 . Clinical laboratory electrocardiogram ( ECG ) abnormality opinion Investigator would endanger subject interfere study conduct . If result clinical laboratory ECG outside normal reference range subject may still enrol finding determine clinically significant Investigator . This determination must record subject 's source document prior enrolment . 14 . Fridericia 's correct QT ( QTcF ) interval great 450 msec 15 . Severe renal impairment ( creatinine &gt; 2 mg/dl ) 16 . Serum total bilirubin &gt; 2.0 mg/dL 17 . Serum aspartate aminotransferase ( AST ) , alanine aminotransferase ( ALT ) , alkaline phosphatase &gt; 2.5 time upper limit normal 18 . Subjects uncontrolled diabetes mellitus , glycosylated hemoglobin ( HbA1c ) &gt; 7.0 % , diabetes mellitus require insulin 19 . Subjects opinion investigator experience rebound headache caffeine usage</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>